Amneal to Participate at the 2022 Jefferies Healthcare Conference
May 24 2022 - 8:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today
announced that Chirag Patel, Co-Chief Executive Officer and
President, and Tasos Konidaris, Chief Financial Officer, will
participate at the 2022 Jefferies Healthcare Conference held on
June 8, 2022 in New York City. Mr. Patel will also be hosting a
presentation which will begin at 8:00 AM Eastern Time and a live
webcast will be accessible through the Investor Relations section
of the Company's website at https://investors.amneal.com. A replay
of the webcast will be posted shortly after the presentation and
will be available for 90 days following the event.
About Amneal Amneal Pharmaceuticals, Inc. (NYSE: AMRX),
headquartered in Bridgewater, NJ, is a fully-integrated essential
medicines company. We make healthy possible through the
development, manufacturing, and distribution of generic and
specialty pharmaceuticals, primarily within the United States. The
Company has a diverse portfolio of over 250 products in its
Generics segment and is expanding across a broad range of complex
products and therapeutic areas, including injectables and
biosimilars. In its Specialty segment, Amneal has a growing
portfolio of branded pharmaceutical products focused primarily on
central nervous system and endocrine disorders, with a pipeline
focused on unmet needs. Through its AvKARE segment, the Company is
a distributor of pharmaceuticals and other products for the U.S.
federal government, retail, and institutional markets. For more
information, please visit www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220524005512/en/
Tony DiMeo Head of Investor Relations
Anthony.DiMeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024